Skip to main content

Advertisement

Log in

Slippery Platelet Syndromes in Subdural Hematoma

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

This study investigates platelet dysfunction in patients with subdural hematomas (SDH) using platelet function analysis (PFA).

Methods

PFA using the PFA-100 (Dade International Inc., Miami, FL) was performed at admission using the collagen–epinephrine and collagen–ADP assays in 58 SDH patients. Clinical and radiologic information was collected.

Results

Normal PFA results were present in 36 patients (62%; PFA collagen:epinephrine assay (s) 118 ave; PFA collagen:adenosine diphosphate assay (s) ave 75) and abnormal platelet function in 22 patients (38%; PFA collagen:epinephrine assay (s) 231 average; PFA collagen:adenosine diphosphate assay (s) 124 average). Compared to patients with normal PFA results, patients with abnormal PFA results were more likely to have hypertension (22 vs. 55%; P = 0.01), take clopidogrel (3 vs. 32%; P = 0.001), and use anti-platelet medications and non-steroidal anti-inflammatory agents (22 vs. 59%; P = 0.004). Measurements of baseline CT for midline shift, maximum thickness, presence of blood/fluid levels in the hematoma, and presence of additional sites of intracranial bleeding did not reveal significant differences based on PFA testing. Platelet dysfunction improved after platelet transfusions (PFA collagen:epinephrine assay: baseline 270 s, CI 61 s; after transfusion 124 s, CI 50 s, P < 0.001).

Conclusion

Platelet dysfunction was found in 38% of SDH patients. This finding adds to our understanding of the pathophysiology of SDH. Since platelet transfusions are indicated for platelet dysfunction accompanied by major bleeding or need for surgery, these results impact peri-operative management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Konig SA, Schick U, Dohnert J, goldammer A, Vitzthum HE. Coagulopathy and outcome in patients with chronic subdural haematoma. Acta Neurol Scand. 2003;107:110–6.

    Article  CAS  PubMed  Google Scholar 

  2. Panicker JN, Pavithran K, Thomas M. Management of subdural hematoma in immune thrombocytopenic purpura: report of seven patients and a literature review. Clin Neurol Neurosurg. 2009;111:189–92.

    Article  CAS  PubMed  Google Scholar 

  3. Leonard A, Shapiro FL. Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med. 1975;82:650–8.

    CAS  PubMed  Google Scholar 

  4. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30:579–89.

    Article  CAS  PubMed  Google Scholar 

  5. Nekludov M, Bellander BM, Blomback M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007;24:1699–706.

    Article  PubMed  Google Scholar 

  6. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51:639–47.

    Article  CAS  PubMed  Google Scholar 

  7. Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398–401.

    Article  PubMed  Google Scholar 

  8. Naidech AM, Bassin SL, Bernstein RA, Batjer HH, Alberts MJ, Lindholm PF, Bleck TP. Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage. Neurocrit Care. 2009 Apr 21. [Epub ahead of print].

  9. Alberts M, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke. 2004;35:175–8.

    Article  CAS  PubMed  Google Scholar 

  10. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med. 2005;142:506–9.

    CAS  PubMed  Google Scholar 

  11. Ng KF, Lawmin JC, Li CC, Tsang SF, Tang WM, Chiu KY. Comprehensive preoperative evaluation of platelet function in total knee arthroplasty patients taking diclofenac. J Arthroplast. 2008;23:424–40.

    Article  Google Scholar 

  12. Rice ML. Acute subdural haemotoma associated with von Willebrand’s disease: a case report. Aust N Z J Surg. 1982;52:86–8.

    Article  CAS  PubMed  Google Scholar 

  13. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost. 1995;21(Suppl 2):106–12.

    PubMed  Google Scholar 

  14. Matzdorff A. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemostasis. 2005;31:393–9.

    Article  CAS  Google Scholar 

  15. Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost. 2007;5:2393–8.

    Article  CAS  PubMed  Google Scholar 

  16. Dickinson KJ, Troxler M, Homer-Vanniasinkam S. The surgical application of point-of-care haemostasis and platelet function testing. Br J Surg. 2008;95:1317–30.

    Article  CAS  PubMed  Google Scholar 

  17. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet. 2006;367:1903–12.

    Article  CAS  PubMed  Google Scholar 

  18. Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, et al. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke. 2007;38:874–80.

    Article  CAS  PubMed  Google Scholar 

  19. Pasa S, Bayan K, Kucukoner M, Tuzun Y, Altintas A, Cil T, et al. The effects of non-steroidal anti-inflammatory drugs on platelet function and severity of upper gastrointestinal haemorrhage. J Thromb Thrombolysis. 2009;28:83–9.

    Article  CAS  PubMed  Google Scholar 

  20. Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, Vercellotti GM. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. J Lab Clin Med. 1988;112:254–63.

    CAS  PubMed  Google Scholar 

  21. Cable R, Carlson B, Chambers L, Kolins J, Murphy S, Tilzer L, Vassallo R, Weiss J, Wissel ME. American Red Cross Practice Guidelines for Blood transfusion: A compilation from recent peer-reviewed literature.Maryland: AABB Press; 2002, p. 15. http://www.redcrosslife.org/hospital/pdf/tmq20.pdf. Accessed May 1, 2009.

Download references

Acknowledgments

The authors are grateful to the Kaiser Permanente hospital, blood bank, and laboratory staff for their important contributions to the care of our neurosurgery patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Taylor Akins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akins, P.T., Guppy, K.H., Sahrakar, K. et al. Slippery Platelet Syndromes in Subdural Hematoma. Neurocrit Care 12, 375–381 (2010). https://doi.org/10.1007/s12028-010-9336-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-010-9336-3

Keywords

Navigation